Happy New Year!
Roger Larson, CAE | Executive Director
January/February 2014
The Child Neurology Society National Office Staff wishes you a happy, healthy, productive 2014. It is a pleasure working with and for you and your 1700 colleagues in the CNS…
Read More
Prepare for the Annual Meeting in Austin
Philip L. Pearl, MD
Fall 2013
As we prepare for the annual meeting in Austin, it is a good time to reflect on PCN progress over the past year. There has been a flurry of activity…
Read More
Q&A With “Retiring” CNS President E. Steve Roach, MD
E. Steve Roach, MD | CNS President
Fall 2013
NOTE: Dr. E. Steve Roach’s two-year tenure as CNS President will end at the conclusion of the CNS Business Meeting on Thursday, October 31, at which point his successor, Dr….
Read More CONNECTIONS – Past, Present & Future
Roger Larson, CAE | Executive Director
Fall 2013
No! I am not Prince hamlet, nor was meant to be; Am an attendant lord, one that will doTo swell a progress, start a scene or two,Advise the prince; no…
Read More Setting a New Course
E. Steve Roach, MD | CNS President
Summer 2013
If you do not change your direction, you are likely to end up where you are headed. – Chinese Proverb The Child Neurology Education and Research Foundation was created in…
Read More Focus on a Universal Curriculum and Case Based Teaching Series – April/May 2013
Philip L. Pearl, MD
April/May 2013
This year’s PCN activities are focused on establishing a content-based universal curriculum for child neurology trainees including a case based teaching series. This work will be coordinated with the efforts…
Read More In Search of the Perfect Meeting Site
E. Steve Roach, MD | CNS President
April/May 2013
You will encounter many people who know the cost of everything and the value of nothing. – Oscar Wilde Until recently I knew little about how the Society selects its…
Read More Clinical Trials for Neurological Diseases – The NEXT Generation
E. Steve Roach, MD | CNS President
January/February 2013
Three decades ago, most of the children with acute lymphoblastic leukemia achieved initial disease remission after chemotherapy, only to later relapse and die. In a stunning reversal, about 95% of…
Read More Mechanism-Based Therapies for Genetic Diseases
E. Steve Roach, MD | CNS President
Fall 2012
Disease is from of old and nothing about it has changed. It is we who change as we learn to recognize what was formerly imperceptible. – Jean Martin Charcot Information…
Read More